This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by White, K. E. Articles by Econs, M. J. Search for Related Content PubMed PubMed Citation Articles by White, K. E. Articles by Econs, M. J. Pubmed/NCBI databases Domain Compound via MeSH Substance via MeSH Medline Plus Health Information Endocrine Diseases

The Roles of Specific Genes Implicated as Circulating Factors Involved in Normal and Disordered Phosphate Homeostasis: Frizzled Related Protein-4, Matrix Extracellular Phosphoglycoprotein, and Fibroblast Growth Factor 23

Department of Medical and Molecular Genetics (K.E.W., T.E.L., M.J.E.) and Department of Medicine (M.J.E.), Indiana University School of Medicine, Indianapolis, Indiana 46202

Correspondence: Address all correspondence and requests for reprints to: Michael J. Econs, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202. E-mail: mecons{at}iupui.edu

Normal serum phosphate (Pi) concentrations are relatively tightly controlled by endocrine mediators of Pi balance. Recent data involving several disorders of Pi homeostasis have shed new light on the regulation of serum Pi balance. It has been hypothesized that circulating phosphaturic factors, or phosphatonins, exist that, when present at high serum concentrations, directly act on the kidney to induce renal Pi wasting. This review will focus upon recently discovered factors that are overexpressed in tumors associated with tumor-induced osteomalacia and have reported activity consistent with effecting Pi balance in vivo. Currently, the best-characterized group of phosphatonin-like polypeptides includes secreted frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor-23. Our understanding of these factors will, in the short term, aid us in understanding normal Pi balance and, in the future, help to design novel therapeutic strategies for disorders of Pi handling.

This article has been cited by other articles:

				F. Jehan, C. Gaucher, T. M. Nguyen, O. Walrant-Debray, N. Lahlou, C. Sinding, M. Dechaux, and M. Garabedian Vitamin D Receptor Genotype in Hypophosphatemic Rickets as a Predictor of Growth and Response to Treatment J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4672 - 4682. [Abstract] [Full Text] [PDF]

				J. Marks, L. J. Churchill, E. S. Debnam, and R. J. Unwin Matrix Extracellular Phosphoglycoprotein Inhibits Phosphate Transport J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2313 - 2320. [Abstract] [Full Text] [PDF]

				G. van Boekel, J. Ruinemans-Koerts, F. Joosten, P. Dijkhuizen, A. van Sorge, and H. de Boer Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling Eur. J. Endocrinol., March 1, 2008; 158(3): 431 - 437. [Abstract] [Full Text] [PDF]

				T. Isakova, O. Gutierrez, A. Shah, L. Castaldo, J. Holmes, H. Lee, and M. Wolf Postprandial Mineral Metabolism and Secondary Hyperparathyroidism in Early CKD J. Am. Soc. Nephrol., March 1, 2008; 19(3): 615 - 623. [Abstract] [Full Text] [PDF]

				H. Dobbie, R. J. Unwin, N. J. R. Faria, and D. G. Shirley Matrix extracellular phosphoglycoprotein causes phosphaturia in rats by inhibiting tubular phosphate reabsorption Nephrol. Dial. Transplant., February 1, 2008; 23(2): 730 - 733. [Abstract] [Full Text] [PDF]

				E. Hesse, H. Rosenthal, and L. Bastian Radiofrequency Ablation of a Tumor Causing Oncogenic Osteomalacia N. Engl. J. Med., July 26, 2007; 357(4): 422 - 424. [Full Text] [PDF]

				H. Segawa, S. Yamanaka, Y. Ohno, A. Onitsuka, K. Shiozawa, F. Aranami, J. Furutani, Y. Tomoe, M. Ito, M. Kuwahata, et al. Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice Am J Physiol Renal Physiol, February 1, 2007; 292(2): F769 - F779. [Abstract] [Full Text] [PDF]

				S. Ferrari Single Gene Mutations and Variations Affecting Bone Turnover and Strength: a Selective 2006 Update IBMS BoneKEy, December 1, 2006; 3(12): 11 - 29. [Abstract] [Full Text] [PDF]

				C. Silve DMP1 and Phosphate Metabolism - Matrix Proteins Go Systemic IBMS BoneKEy, December 1, 2006; 3(12): 30 - 35. [Full Text] [PDF]

				G. J. Strewler Bone Talk: Klotho and FGF23 Signaling IBMS BoneKEy, December 1, 2006; 3(12): 36 - 40. [Full Text] [PDF]

				E. Schipani, S. Ferrari, N. S. Datta, L. K. McCauley, A. Vignery, T. Bellido, G. J. Strewler, C. H. Turner, Y. Jiang, and E. Seeman Meeting Report from the 28th Annual Meeting of the American Society for Bone and Mineral Research IBMS BoneKEy, November 1, 2006; 3(11): 14 - 50. [Full Text] [PDF]

				K. Kato, C. Jeanneau, M. A. Tarp, A. Benet-Pages, B. Lorenz-Depiereux, E. P. Bennett, U. Mandel, T. M. Strom, and H. Clausen Polypeptide GalNAc-transferase T3 and Familial Tumoral Calcinosis: SECRETION OF FIBROBLAST GROWTH FACTOR 23 REQUIRES O-GLYCOSYLATION J. Biol. Chem., July 7, 2006; 281(27): 18370 - 18377. [Abstract] [Full Text] [PDF]